🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Now live at #ESOC2021➡️ Prof. Signild Åsberg & Prof. Jonas Oldgren presenting the results of the TIMING #stroke #clinicaltrial study looking at the timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation. #neurotwitter #neurology

Congrats, TIMING team for these extremely important results! The low bleeding rates are reassuring and we now have to keep randomizing to get more evidence on the net benefit of an early treatment approach!

#BloggingStroke contributor Vignan Yogendrakumar Vignan Yogendrakumar discusses highlights from the Closing Ceremony and Large Clinical Trials 2 session at #ESOC2021 #stroke European Stroke Org ow.ly/4TLX50G5J1w

Here at #ISC22. Getting ready to present the CERTAIN Collaboration’s large study showing a significant reduction in symptomatic intracranial hemorrhage using tenecteplase instead of alteplase for stroke. Dell Medical School Lone Star Stroke Research Consortium Ascension Stroke AHA/ASA

It has been a privilege to work and collaborate with so many wonderful stroke scientists across Europe&New Zealand🧠💫It was an absolute honour to present TWIST stroke trial results at #ESOC2022 yesterday! Thank you! Gian Marco De Marchis, MD MSc Erik Lundström Jesper Petersson Professor Hanne Christensen Teddy Wu

Very important trial on timing of DOAC therapy in patients with stroke and AF. Intriguing to see ischemic event rates in the first days after index stroke in early vs. Late group. Waiting for The ELAN Trial and OPTIMAS Urs Martin Fischer UCL Stroke Research ahajournals.org/doi/abs/10.116…

#TIMING Early vs delayed #NOAC start after acute ischemic stroke 🧠💊🩸 Bo Norrving 👏 Presented at #ESOC2021, now you can read the full article here 👇🏻 ahajournals.org/doi/abs/10.116…

First proof of TIMING result published. Great teamwork makes anything possible. ⁦Bo Norrving⁩ ahajournals.org/doi/abs/10.116…

The new 2023 National Clinical Guideline (strokeguideline.org) has a recommendation for patients with moderate/severe ischaemic stroke: "wherever possible these patients should be offered participation in a trial of the timing of initiation of anticoagulation after stroke"

Discussing biomarkers, rhythm control and anticoagulation in an interactive set up with lively participation. Thank you @maeritjensen, Mira Katan, Signild Åsberg, Hooman Kamel, Charlotte Cordonnier, Daniel Bereczki #strokescience #strokecommunity #ESSW

Signild Åsberg earlier gave us a comprehensive overview of registry-based RCTs! #ESOC2024

Congratulations to Bo Norrving who received the European Stroke Org Honorary Award this year for his incredible work in stroke care, research and advocacy! #ESOC2024

David G. Sherman Lecture by Steven Warach: A shift toward selection and evaluation of #stroke patients for therapies based on direct observation of target pathology and away from clinical and temporal surrogates. ahajrnls.org/4dO8Gma AHA Science Dell Medical School UT Health Austin

Don't miss the presentation of the OPTIMAS and CATALYST results this week at #WSC2024, which will be featured in Day 2's plenary session!

#WSC2024 Following the #Optimas results, Dr. Signild Åsberg presented the much-anticipated #CATALYST IPD meta-analysis on early vs. late DOAC initiation after stroke in AF patients #TIMING #ELAN #OPTIMAS #START 👏Early start better for composite PO: IS/sICH/unclasiffied stroke

WSO & ESO joint webinar on uncovering key insights from the World Stroke Congress 2024. 📑 ow.ly/oZNn50U4rtv 📅 20 November 2024,17:00 CET 📜 Luciano Sposato 🇦🇷🇨🇦, Signild Åsberg, Urs Martin Fischer 🎙️ Jeyaraj Pandian & Simona Sacco #stroke #neurology #stroketwitter World Stroke Org

🧠 The European Stroke Science Workshop, ESSW, brings together leading clinician-scientists and researchers in a highly interactive setting. Applications for mid-career researchers who are ESO members are open until 25 April 2025 – 👉 ow.ly/zFW150Vsn2g #stroke

Many thanks to all the CATALYST collaborators, who helped us to solve this old dilemma in acute stroke management: there is no reason to delay anticoagulants in ischemic stoke patients with atrial fibrillation! Insel Gruppe Stroke Research Center Bern Universität Bern

The Lancet Very happy to see this in print, the result of 8 years of collaboration between the RCT:s on this topic. The final result of the individual patient data systematic analysis showed that the total was larger than the parts; a demonstration of the power of evidence based principles